Cryoport has opened a new facility at its integrated supply chain campus in Houston, Texas, to develop its IntegriCell™ cryopreservation services solution.
IntegriCell is a standardised bioprocessing, cryopreservation, and distribution solution for the global cell and gene therapy market. The platform is designed to enhance cell therapy manufacturing and flexibility to support lifesaving treatments.
The new facility will specifically focus on the standardised cryopreservation of leukapheresis material. The new offering will be integrated into Cryoport’s temperature-controlled supply chain platform.
Read more: How Cryoport stays ahead in delivering cell and gene therapies
... to continue reading you must be subscribed
